The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...

CVS Health Corporation is a vertically integrated healthcare corporation in the United States. The company owns a leading ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

The report is the latest indictment of America’s broken healthcare system.

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

Optum RX, CVS Caremark and Express Scripts are marking up drugs that treat cancer and multiple sclerosis by more than ...

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...